3-OS HS	3-O-sulphated heparan sulphate
BAC	bacterial artificial chromosome
BIRC5	baculoviral inhibitor of apoptosis repeat-containing 5
CEA	carcinoembryonic antigen
CTL	cytotoxic T lymphocyte
CTLA-4	CTL antigen-4
CYP2B1	cytochrome P450, family 2, subfamily b, polypeptide 1
EGFP	enhanced green fluorescent protein
EGFR	epidermal growth factor receptor
EGFRvIII	epidermal growth factor receptor variant III
EMA	European Medicines Agency
FDA	Food and Drug Administration (USA)
GALV	gibbon ape leukemia virus
GBM	glioblastoma multiforme
GM-CSF	granulocyte macrophage colony-stimulating factor (GM-CSF)
GMP	Good Manufacturing Practice
GSCs	glioblastoma stem-like cells
HCMV	human cytomegalovirus
HER2	human epidermal growth factor receptor 2
HS	heparan sulphate
HveA	herpesvirus entry mediator A
HveC	herpesvirus entry mediator C
HVEM	herpesvirus entry mediator
ICI	immune-checkpoint inhibitor
ICP	infected cell protein
IL	interleukin
MAG	myelin-associated glycoprotein
NMHC-II	non-muscle myosin heavy chain II
N-ter	amino terminus
OPTiM	OncoVEXGM-CSF Pivotal Trial in Melanoma
OV	oncolytic virus
PD-1	programmed cell death 1
PD-L1	programmed cell death 1 ligand 1
PILRα	paired immunoglobulin-like type 2 receptor-α
PKR	protein kinase R
PSMA	prostate-specific membrane antigen
RR	ribonucleotide reductase
scFv	single chain antibody variable fragment
ScGCs	serum-cultured GBM cells
TK	thymidine kinase
UL	unique long
uPA	urokinase-type plasminogen activator
uPAR	urokinase-type plasminogen activator receptor
US	unique short
wt	wild type
yCD	yeast cytosine deaminase
Δ	deletion